Benjamin Frishberg

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

Botulinum Toxin Type A (BOTOX ^® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Ninan T. Mathew, Benjamin Frishberg, Marek Gawel et al. · Headache The Journal of Head and Face Pain · 2005 · 263 citations

Cell Therapy for Chronic TBI

Masahito Kawabori, Alan Weintraub, Hideaki Imai et al. · Neurology · 2021 · 77 citations · Full text

<i>Temporarily Withdrawn:</i>Choosing Wisely in Headache Medicine: The American Headache Society's List of Five Things Physicians and Patients Should Question

Elizabeth Loder, Emma Weizenbaum, Benjamin Frishberg et al. · Headache The Journal of Head and Face Pain · 2013 · 46 citations

Cluster Headache, Full Text, Engineering +14